Opioid-Induced Hyperalgesia in Chronic Pain Patients and the Mitigating Effects of Gabapentin
Chronic pain patients receiving opioid drugs are at risk for opioid-induced hyperalgesia (OIH), wherein opioid pain medication leads to a paradoxical pain state. OIH involves central sensitization of primary and secondary afferent neurons in the dorsal horn and dorsal root ganglion, similar to neuro...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Book |
| Published: |
Frontiers Media S.A.,
2015-05-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_b50cb7a984ba48c48d2e386e77c40dcf | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Nicoleta eStoicea |e author |
| 700 | 1 | 0 | |a Daric eRussell |e author |
| 700 | 1 | 0 | |a Greg eWeidner |e author |
| 700 | 1 | 0 | |a Michael eDurda |e author |
| 700 | 1 | 0 | |a Nicholas Christopher Joseph |e author |
| 700 | 1 | 0 | |a Jeffrey eYu |e author |
| 700 | 1 | 0 | |a Sergio Daniel Bergese |e author |
| 700 | 1 | 0 | |a Sergio Daniel Bergese |e author |
| 245 | 0 | 0 | |a Opioid-Induced Hyperalgesia in Chronic Pain Patients and the Mitigating Effects of Gabapentin |
| 260 | |b Frontiers Media S.A., |c 2015-05-01T00:00:00Z. | ||
| 500 | |a 1663-9812 | ||
| 500 | |a 10.3389/fphar.2015.00104 | ||
| 520 | |a Chronic pain patients receiving opioid drugs are at risk for opioid-induced hyperalgesia (OIH), wherein opioid pain medication leads to a paradoxical pain state. OIH involves central sensitization of primary and secondary afferent neurons in the dorsal horn and dorsal root ganglion, similar to neuropathic pain. Gabapentin, a gamma-aminobutyric acid (GABA) analogue anticonvulsant used to treat neuropathic pain, has been shown in animal models to reduce fentanyl hyperalgesia without compromising analgesic effect. Chronic pain patients have also exhibited lower opioid consumption and improved pain response when given gabapentin. However, few human studies investigating gabapentin use in OIH have been performed in recent years. In this review, we discuss the potential mechanisms that underlie OIH and provide a critical overview of interventional therapeutic strategies, especially the clinically-successful drug gabapentin, which may reduce OIH. | ||
| 546 | |a EN | ||
| 690 | |a NMDA | ||
| 690 | |a neuropathic pain | ||
| 690 | |a allodynia | ||
| 690 | |a Opiods | ||
| 690 | |a gabapentin | ||
| 690 | |a VGCCs | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Frontiers in Pharmacology, Vol 6 (2015) | |
| 787 | 0 | |n http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00104/full | |
| 787 | 0 | |n https://doaj.org/toc/1663-9812 | |
| 856 | 4 | 1 | |u https://doaj.org/article/b50cb7a984ba48c48d2e386e77c40dcf |z Connect to this object online. |